Volume 15, No 1, Jan 2005

ISSN: 1001-0602 
EISSN: 1748-7838 2018 
impact factor 17.848* 
(Clarivate Analytics, 2019)

Volume 15 Issue 1, January 2005: 19-23

REVIEWS

Modulation of the MAP kinase signaling cascade by Raf kinase inhibitory protein

Nicholas TRAKUL, Marsha R. ROSNER*

Ben May Institute for Cancer Research, University of Chicago, 5841 S. Maryland Avenue., Chicago, IL 60637, USA Correspondence: Marsha Rich ROSNER(m-rosner@uchicago.edu)

Proteins like Raf kinase inhibitory protein (RKIP) that serve as modulators of signaling pathways, either by promoting or inhibiting the formation of productive signaling complexes through protein-protein interactions, have been demonstrated to play an increasingly important role in a number of cell types and organisms. These proteins have been implicated in development as well as the progression of cancer. RKIP is a particularly interesting regulator, as it is a highly conserved, ubiquitously expressed protein that has been shown to play a role in growth and differentiation in a number of organisms and can regulate multiple signaling pathways. RKIP is also the first MAP kinase signaling modulator to be identified as playing a role in cancer metastasis, and identification of the mechanism by which it regulates Raf-1 activation provides new targets for therapeutic intervention.

FULL TEXT | PDF

Browse 1930